Managing Haemophilia: Treatment, Lifestyle, and Coping Strategies

Haemophilia is a lifelong genetic condition that affects the blood’s ability to clot, but a diagnosis does not have to define the quality of a person’s life. With the right treatment plan, smart lifestyle choices, and strong psychological support, people with haemophilia can live active, fulfilling lives. Managing the condition effectively requires understanding three interconnected dimensions: medical treatment, daily lifestyle adjustments, and mental well-being. This post walks through each of these areas in detail.

Can haemophilia be prevented? 🔗

Since haemophilia is an inherited genetic disorder – caused by mutations in the genes responsible for producing clotting factors VIII (haemophilia A) or IX (haemophilia B) – it cannot be prevented in the traditional sense. However, families with a known history of haemophilia can take informed steps before and during pregnancy.

The role of genetic counselling 🔗

Genetic counselling is an integral part of comprehensive haemophilia care. It provides individuals and families with clinical and scientific information, supports them through decision-making around carrier and prenatal testing, and offers personalised psychosocial assessment before and after genetic testing. Genetic counselling touches on sensitive issues related to childbearing and family planning – and importantly, it helps reduce guilt, resentment, and blame when couples can openly explore their options in a neutral, supported environment.

Genetic counsellors help families understand the risks and available options, including prenatal diagnosis and carrier testing. They work within multidisciplinary haemophilia treatment centres, adapting their guidance to the patient’s understanding and beliefs.

Prenatal testing options 🔗

For families where haemophilia is a known risk, several prenatal testing approaches are available. According to Liv Hospital’s clinical guidance, these include:

• Chorionic Villus Sampling (CVS): Performed at around 10-12 weeks of pregnancy, CVS takes cells from the placenta to detect genetic conditions like haemophilia early in the first trimester.
• Amniocentesis: Carried out between 15 and 20 weeks, this test analyses DNA in the amniotic fluid to confirm a haemophilia diagnosis.
• Non-Invasive Prenatal Testing (NIPT): This analyses fetal DNA in the mother’s blood and can indicate elevated risk, often serving as a first step before more invasive testing.
• Pre-implantation Genetic Diagnosis (PGD): For families opting for IVF, PGD can identify embryos carrying the haemophilia mutation before implantation, giving parents the option to select embryos without the condition.

Crucially, prenatal testing should always be a personal choice, offered under non-directive counselling that ensures the mother fully understands all possible risks and benefits. Ethical considerations – including the autonomy and well-being of the woman – must always remain at the centre of any decision.

Medical treatment: the cornerstone of haemophilia management 🔗

While there is currently no cure for haemophilia (though gene therapy is showing promise), its management has advanced significantly. Treatment focuses on replacing or supplementing the deficient clotting factors to prevent or control bleeding.

Prophylactic treatment: preventing bleeds before they happen 🔗

Prophylaxis – the regular, scheduled infusion of clotting factor concentrates – is now considered the standard of care for people with severe haemophilia. The goal is to maintain clotting factor levels consistently above 1 IU/dL (1%), and ideally above 3-5%, to minimise the risk of spontaneous bleeding.

The International Society on Thrombosis and Haemostasis (ISTH) strongly recommends prophylaxis over episodic (on-demand) treatment for patients with severe and moderately severe haemophilia A and B. Episodic treatment – treating bleeds only after they occur – does not change the natural history of the disease and can allow cumulative joint damage over time.

Modern prophylactic options include:

• Standard half-life factor concentrates: Typically given two to four times per week for haemophilia A, or two to three times per week for haemophilia B.
• Extended half-life (EHL) concentrates: These newer products require less frequent infusions – sometimes just once or twice weekly – reducing the treatment burden while maintaining protective factor levels.
• Emicizumab (Hemlibra®): A humanised monoclonal bispecific antibody administered subcutaneously (under the skin), emicizumab is the only approved non-factor replacement therapy. It is approved for haemophilia A patients of all ages, with or without inhibitors, and is a significant advancement in reducing infusion frequency.

Starting prophylaxis early in life is strongly recommended, as it reduces the risk of intracranial haemorrhage and protects joint health from a young age – outcomes that have a lasting impact on long-term quality of life.

Managing acute bleeding episodes 🔗

Even with prophylaxis, bleeding episodes can still occur – particularly after an injury or during periods of high physical activity. Prompt management is critical to limit tissue damage, especially in joints like the ankles, knees, and elbows, which are the most commonly affected.

According to the World Federation of Hemophilia (WFH) guidelines, patients with joint bleeds (haemarthrosis) should be treated immediately with intravenous infusions of replacement clotting factor concentrate. Pain management can include paracetamol, COX-2 inhibitors, or tramadol, alongside the RICE approach – Rest, Ice, Compression, and Elevation – to reduce swelling and limit further bleeding.

Speed matters: in critical situations, people with haemophilia need immediate access to emergency medicines, treatment, and specialist care. Lack of awareness about haemophilia in general emergency departments remains a genuine risk and highlights the importance of having a documented emergency care plan.

Comprehensive, multidisciplinary care 🔗

Effective haemophilia management goes well beyond clotting factor infusions. It is best practice to refer all persons with haemophilia to a designated haemophilia treatment centre, where a team of specialists can develop a personalised, shared-decision-making care plan. A well-functioning multidisciplinary team typically includes:

• Haematologists: Specialists who oversee the medical management of the condition, including factor replacement therapy and monitoring for inhibitor development.
• Physiotherapists: Crucial for maintaining joint health, preventing musculoskeletal complications, and guiding safe physical activity. Regular physiotherapy helps maintain joint health and slow the development of chronic arthropathy.
• Mental health professionals: Psychologists and counsellors who address the emotional and psychological aspects of living with a chronic condition.
• Nurses and social workers: These professionals coordinate services, provide patient education, and offer practical support for daily management challenges.

Lifestyle management: reducing risk without limiting life 🔗

Haemophilia does not mean living in a bubble. But it does require thoughtful, consistent choices about physical activity, diet, and safety practices. The goal is to minimise injury risk while preserving an active, enjoyable lifestyle.

Choosing the right physical activities 🔗

Physical activity is actually encouraged for people with haemophilia – strong muscles protect joints from bleeds. However, the type of activity matters. High-contact sports like football, rugby, or martial arts carry a significantly elevated injury risk and are generally avoided. Instead, low-impact activities such as swimming, cycling, walking, and golf are recommended. These provide cardiovascular benefits and maintain muscle strength with minimal risk of trauma.

When physical activity does take place, protective gear is essential. Helmets, knee pads, and joint padding provide a practical first line of defence against accidental injury, especially for children who are naturally more active and exploratory.

Diet and nutrition 🔗

While diet alone cannot treat haemophilia, specific nutritional choices can support the body’s clotting mechanisms. Vitamin K, found in leafy green vegetables like spinach, kale, broccoli, and Brussels sprouts, plays a key role in the clotting cascade. Including these foods regularly in the diet provides natural support for the coagulation process.

It is important, however, to maintain a consistent Vitamin K intake rather than dramatically increasing it suddenly, as fluctuating levels can interact with some medications. A balanced, protein-rich diet also supports tissue repair and overall health.

Staying well hydrated is equally important – dehydration can have compounding negative effects on overall health and should be avoided, particularly during physical activity or warm weather.

First aid and emergency preparedness 🔗

For any bleeding episode, prompt first aid is critical. Even minor cuts or bruises should be taken seriously, and any suspected internal bleed – particularly in joints – requires immediate medical attention. People with haemophilia are encouraged to carry an emergency medical card detailing their diagnosis, factor levels, and current treatment plan, ensuring that first responders and emergency departments can act quickly and appropriately.

Avoiding medications that thin the blood further – most notably aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) – is also a key safety practice. These drugs interfere with platelet function and can significantly worsen a bleeding episode.

Coping with the psychological impact of haemophilia 🔗

The physical demands of haemophilia are visible and well-documented. The psychological challenges are equally real but often receive less attention. Research consistently shows that quality of life is reduced in people with haemophilia, with a measurable impact on education, employment, and social participation – particularly when prophylactic treatment is not accessible.

Understanding the emotional burden 🔗

Living with a chronic condition that requires ongoing vigilance, frequent medical visits, and constant awareness of injury risk takes a significant emotional toll. Anxiety about bleeds, depression, frustration, and social isolation are common experiences for people with haemophilia and their families. The psychological burden begins early – often at the point of genetic counselling and prenatal diagnosis – and can affect couple dynamics, parenting, and family relationships throughout life.

Psychosocial support is a vital part of comprehensive haemophilia care. Medical treatment alone does not automatically translate into better quality of life; addressing the social and emotional dimensions of the condition is equally important.

Professional counselling and therapy 🔗

Mental health professionals who understand chronic medical conditions can provide targeted, effective support. Recommended counselling approaches include:

• Mindfulness-based stress reduction: Incorporates meditation and breathing techniques to manage anxiety and promote emotional stability.
• Supportive counselling: Provides a safe space to express fears and concerns related to haemophilia without judgement.
• Problem-solving therapy: Builds practical skills for navigating daily challenges, from managing treatment schedules to communicating with employers or schools about accommodations.
• Coping skills training: Equips individuals with stress management and emotional regulation tools to foster resilience.

Family therapy is also highly beneficial – particularly for parents of young children recently diagnosed with haemophilia. The emotional strains associated with a newly diagnosed child can have a significant impact on couple dynamics and the broader family system, and professional support at this stage can prevent longer-term difficulties.

The power of peer support and community 🔗

Psycho-educational interventions – providing information and early coping strategies to individuals and their families – have been shown to improve self-management abilities and disease-specific knowledge in people with haemophilia. Support groups, whether local or online, connect people with shared experiences, reducing the isolation that can accompany a rare chronic condition.

Social anxiety can lead people with haemophilia to withdraw from social life – and this withdrawal itself worsens mental health outcomes. Gradual, supported social re-engagement – starting with one trusted person and slowly expanding – is a practical and evidence-backed approach to rebuilding connection.

Open communication with family and friends about feelings, fears, and daily needs is equally important. Honest conversations make the journey less lonely and help loved ones understand what meaningful support looks like in practice. Maintaining steady-state wellbeing – physical and emotional – with low treatment burden and high quality of life remains the overarching goal of modern haemophilia care.

What do you think? If you were designing a care plan for someone newly diagnosed with haemophilia, which aspect – medical treatment, lifestyle adjustment, or psychological support – do you think is most frequently overlooked, and why? And how might teachers and educators play a role in supporting students with haemophilia in school settings?

References

1. https://elearning.wfh.org/resource/genetic-counselling-for-hemophilia/
2. https://pubmed.ncbi.nlm.nih.gov/10215953/
3. https://www1.wfh.org/publication/files/pdf-1160.pdf
4. https://int.livhospital.com/hemophilia-prevention-genetic-counseling-women/
5. https://hemaware.org/life/genetic-counseling
6. https://onlinelibrary.wiley.com/doi/10.1111/hae.14805
7. https://onlinelibrary.wiley.com/doi/10.1111/hae.14046
8. https://www.jthjournal.org/article/S1538-7836(24)00318-0/fulltext
9. https://www.bleeding.org/healthcare-professionals/guidelines-on-care/masac-documents/masac-document-267-masac-recommendation-concerning-prophylaxis-for-hemophilia-a-and-b-with-and-without-inhibitors
10. https://www.rarediseaseadvisor.com/disease-info-pages/hemophilia-guideline-recommendations/
11. https://www.hematologyadvisor.com/features/isth-guidelines-hemophilia/
12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114907/
13. https://pubmed.ncbi.nlm.nih.gov/22059839/
14. https://pubmed.ncbi.nlm.nih.gov/20579110/
15. https://onlinelibrary.wiley.com/doi/10.1111/hae.14926
16. https://hemophilianewstoday.com/hemophilia-and-mental-health/
17. https://pmc.ncbi.nlm.nih.gov/articles/PMC7080553/
18. https://pmc.ncbi.nlm.nih.gov/articles/PMC12158498/